Dr RR Baliga's "Got Knowledge Doc" Podkast

📘 New Evidence from NEJM In a large meta-analysis of 17,801 patients with preserved LVEF after MI, beta-blockers did not reduce death, recurrent MI, or heart failure. Event rates were low, and outcomes were similar with or without therapy. 🫀📊 This clarifies practice for a growing post-MI population with LVEF ≥50%—precision matters more than tradition. 🎯 Full study: New England Journal of Medicine (2025). #Cardiology 💙 #ClinicalEvidence #MI #HeartHealth

📢 ADAPT AF-DES Trial — A Safer Path Forward! In patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation, NOAC monotherapy delivered striking benefits over combination therapy. ✅ Lower net adverse clinical events ✅ Marked reduction in major/CRNM bleeding ✅ Similar ischemic protection A beautifully simple strategy with meaningful impact. Published in NEJM (2025). 💊🛡️📉💓

🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation. 🧠 96% had no new infarcts on MRI at follow-up. Published in NEJM (2025) — a valuable contribution to nuanced AF post-ablation care.

🧠 John Locke: Experience • Liberty • Toleration Born a physician-philosopher, Locke championed empiricism — the idea that knowledge begins with experience, not dogma. His tabula rasa shaped modern psychology, while his Two Treatises of Government defined rights, consent, and freedom that echo through modern democracies. For clinicians, his legacy reminds us to: 🔹 Trust observation and evidence over authority 🔹 Respect patient autonomy and informed consent 🔹 Foster pluralism and toleration in care His vision of reason and tolerance remains medicine's quiet ally. 🕊️📜💬 Observation. Reflection. Compassion.

🚀 VESALIUS-CV delivers powerful evidence: in high-risk patients without prior MI or stroke, evolocumab significantly reduced 3-point MACE by 25% and 4-point MACE by 19%, with LDL-C lowered to a median of 45 mg/dL. 💡 These results expand the horizon of prevention, showing that deep LDL reduction is both safe and effective in averting first cardiovascular events. 🫀 Strong science. Clear signal. A new chapter in preventive cardiology. #Cardiology #LDL #Prevention #VESALIUSCV

🫀 Septic Shock, Refined at the Fingertips ⏱️ A powerful new JAMA (2025) trial brings us one step closer to truly personalized resuscitation. The ANDROMEDA-SHOCK-2 study shows that targeting capillary refill time (CRT) — a simple bedside sign — can shorten time on organ support vs usual care, without increasing mortality. Key insight: Sometimes the most elegant solutions are low-tech, high-touch, and right at the bedside. 🧠 Precision 🤚 Physiology 💡 Pragmatism #Sepsis #CriticalCare #PersonalizedMedicine #JAMA #Hemodynamics #ICU #Shock

🚨 SOFA-2 arrives — a thoughtful evolution in critical care scoring 🧠🫁🫀 After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving simplicity and bedside usability. A meaningful step forward in describing organ dysfunction — with room for future biologically grounded refinement. 📖 Published in JAMA

SOFA-2 is here — a major advance in assessing organ dysfunction in critical illness 🧠🫁❤️ Three decades after the original SOFA score, this updated framework reflects modern ICU practice — integrating contemporary organ support (ventilation, vasopressors, RRT), delirium recognition, and global feasibility across resource settings 🌍📊 Validated in 3.3M+ ICU patients across 9 countries — a remarkable effort in global critical care science 🏥📈 A powerful step forward in our shared language of severity and recovery. 🔗 JAMA Network Open, 2025

💔 Peripartum Cardiomyopathy: When a Mother's Heart Fights for Two Peripartum cardiomyopathy is a leading yet often missed cause of maternal morbidity and mortality—striking late in pregnancy or months postpartum. Early suspicion, timely echo, and guideline-directed therapy save lives. 🩺 🧠 Bromocriptine, careful anticoagulation, and multidisciplinary care are reshaping outcomes, but global disparities persist. 🌍 Let's amplify awareness, strengthen systems, and protect mothers everywhere. 🤝❤️ #HeartFailure #MaternalHealth #Cardiology #GlobalHealth #PPCM

Rethinking "default lines" in the ICU 🧠🚑 A landmark NEJM trial shows that in patients with shock, deferring arterial catheterization and using automated cuff monitoring was noninferior for 28-day mortality — and reduced catheter-related complications. A gentle reminder: not every sick patient needs a needle to be well cared for. Precision isn't only invasive — sometimes it's thoughtful, measured, humane. 🌿💡 #CriticalCare #ICU #NEJM #Shock #Hemodynamics #PatientSafety

🌙 Bright Nights, Higher Heart Risk ❤️‍🩹 New findings in JAMA Network Open highlight that greater exposure to artificial light at night is associated with significantly increased risks of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke — independent of sleep duration, lifestyle factors, and genetics. 💡 Clinical takeaway: Protecting circadian rhythms is cardiovascular prevention. Darker nights = healthier hearts. 🛌 Simple steps: blackout curtains, limit screens before bed, use warm/dim evening lighting. #Cardiology #JAMANetworkOpen #CircadianHealth #SleepMedicine #PrecisionPrevention #PublicHealth

The immune clock starts earlier than we think ⏳🧬 A landmark Nature study shows that immune aging begins quietly in midlife — decades before clinical frailty. Using >16M single-cell profiles and longitudinal vaccine responses, researchers found: • Stable, early transcriptional drift in naïve & memory T cells • A subtle TH2 shift that may weaken antiviral antibody quality • Reduced IgG class-switching to repeat flu antigens (e.g., B/Phuket) • No acceleration from CMV infection despite compositional shifts The message? Immune aging is gradual, not abrupt — and midlife may be the window for intervention. Precision immunology will increasingly mean precision geroscience.

🫀 TAVR or SAVR? The 7-Year Truth New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes. 🔎 Highlights • Composite events: 34.6% (TAVR) vs 37.2% (SAVR) • Mortality: 19.5% vs 16.8% • Valve failure: 6.9% vs 7.3% • Aortic gradients remain low in both groups 💡 Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak. This study reinforces a simple truth: in the right low-risk patient, TAVR is not just less invasive — it's durable. #Cardiology #StructuralHeart #AorticStenosis #TAVR #SAVR #NEJM

🌿 Spinoza: Reason, Nature, Freedom Today's deck explores Baruch Spinoza — the quietly revolutionary Dutch philosopher who shaped rationalism, modern biblical criticism, and secular democracy. He saw God = Nature, championed intellectual freedom, and argued that understanding our emotions transforms them — not far from cognitive-behavioral ideas we use in modern medicine. His reminder feels timely: human flourishing grows where inquiry is free, passions are understood, and systems support dignity + reason. 🧠🔍💬 Clarity is liberation.

A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER. A third pathway for mitral disease is emerging—one built on precision access, valve-in-valve durability planning, and advancing patient selection. Innovation meeting clinical need. 🚀🫀📈

🧬 Can we rejuvenate the aging immune system? A remarkable Nature Biotechnology study shows that a rare population of periostin-positive mesenchymal niche cells can rebuild the adult thymus, recruit new T-cell progenitors, and restore immune responses after injury. By harnessing CCL19-expressing stromal support, the authors demonstrate a path toward immune renewal in aging, cancer therapy recovery, and HSCT survivors. ✨ A glimpse of regenerative immunology's future: Rebuild. Recruit. Rejuvenate. #Immunology #Aging #RegenerativeMedicine #Thymus #TCells #PrecisionMedicine #ImmuneHealth

🩺🎗️ Cardio-Oncology Insight: Not Every Breast Cancer Survivor Needs a Cardiologist As breast cancer survivorship grows, understanding who truly benefits from long-term cardiac follow-up becomes essential. An important editorial in JAMA Oncology underscores a key principle: risk-stratified care, not reflex surveillance. 👩‍⚕️🔍 Age and traditional cardiovascular risk factors outweigh treatment exposure (including anthracyclines and ERBB2 therapy) in driving late heart failure and cardiomyopathy risk among survivors . 🏥💡 Most survivors can be safely followed by primary care clinicians focused on: • Controlling blood pressure, diabetes, lipids • Encouraging physical activity & healthy weight • Monitoring symptoms and functional status ❤️📊 Select high-risk patients — older age, multiple CV risk factors, or treatment-related dysfunction — benefit most from targeted cardio-oncology evaluation. This editorial reminds us that precision survivorship means personalizing cardiac follow-up, emphasizing prevention, equity, and collaboration between oncology, cardiology, and primary care. 🌱 Goal: Survivors who not only live longer — but live well. #CardioOncology #BreastCancer #Survivorship #HeartFailurePrevention #PrecisionMedicine #PrimaryCare #JAMAOncology #CancerCare #CardioOnc #PopulationHealth #AcademicMedicine

🧬 Can we rejuvenate the aging immune system? A new Nature Aging trial suggests we might be closer than we thought. In 50 healthy adults aged 45–70, urolithin A—a mitophagy activator—improved immune fitness over just 28 days: ✅ ↑ naïve CD8⁺ T cells ✅ ↓ exhaustion markers (TOX) ✅ ↑ mitochondrial biogenesis (PGC-1α) ✅ ↑ fatty-acid oxidation capacity ✅ ↑ NK cell and monocyte function ✅ ↑ bacterial phagocytosis 💊 Well-tolerated with minimal adverse events 🔬 This builds on compelling translational work linking mitochondrial quality control to immunosenescence and "inflammaging." A reminder that metabolism and immunity are deeply intertwined—and that targeted interventions may help preserve immune resilience across the lifespan. 🧠 Aging isn't just years lived. It's biology modulated. #LongevityScience #Immunology #HealthyAging #Mitochondria #ClinicalResearch #TranslationalScience #Geroscience #ImmuneHealth #NatureAging

🫀 Personalizing DAPT: When "One Size Fits All" Fails 🕊️💊 The HOST-BR trial in The Lancet offers an important clinical lesson: Bleeding risk should guide antiplatelet duration after PCI — not habit, not inertia. 🔍 Key insight In ARC-HBR patients, 1-month DAPT was not non-inferior to 3 months In non-HBR patients, 3-month DAPT was non-inferior to 12 months and reduced bleeding 🧠 Clinical takeaway ➡️ Ultra-short (1-mo) DAPT is risky in high-bleeding-risk patients ➡️ Short (3-mo) DAPT is safe and bleeding-sparing in lower-risk patients 🔧 Precision medicine in action: Stratify → Tailor → Protect 📎 HOST-BR | The Lancet (2025) A beautiful reminder that medicine advances when we match therapy to physiology — not the other way around. 🌟 "Do no harm" is evolving… now it means do no unnecessary bleeding. #Cardiology #InterventionalCardiology #PrecisionMedicine #DAPT #PCI #BleedingRisk #Lancet

🚨 New Pharmacotherapy for Obstructive Sleep Apnoea 🌙💊 In a landmark Phase 2 trial published in The Lancet, sultiame— a carbonic anhydrase inhibitor—showed dose-dependent reduction in AHI and improved nocturnal oxygenation in adults with moderate–severe OSA. 💡 Key insights: • 298 participants across 5 European countries • 200 mg daily delivered the best efficacy-to-tolerability balance • Benefits most notable in sleepy phenotypes (ESS >10) • Mild, dose-related paraesthesia most common AE 🔬 A promising step toward precision sleep medicine and pharmacologic options for patients who struggle with CPAP. 🌬️ Better breathing by night → brighter cognition by day. 📖 Lancet, 2025 — FLOW Study (Randerath et al.)

📢 New Study Alert 🩺💊 In JAMA Internal Medicine, a national analysis reveals that using the PREVENT risk calculator (vs Pooled Cohort Equations) dramatically reduces the number of U.S. adults aged 40–59 eligible for aspirin in primary prevention of cardiovascular disease. Among 7.6 million current aspirin users, >96% wouldn't qualify by PREVENT 🤯. Time to rethink our calculators and consider deprescribing where net benefit is questionable. 📰 Read more: https://jamanetwork.com/journals/jamainternmed/fullarticle/10.1001/jamainternmed.2025.5049

🧠 TACSI Trial in NEJM (Sep 2025) challenges the status quo on dual antiplatelet therapy after CABG for ACS! 👨‍⚕️ 2201 patients across 5 Nordic countries 💊 Ticagrelor + Aspirin ≠ better outcomes vs Aspirin alone 📉 No reduction in death, MI, stroke, or revascularization 🩸 But bleeding (4.9% vs 2.0%) & dyspnea (18.2% vs 6.4%) increased 📚 Guidelines may need rethinking. 📖 Jeppsson A et al. N Engl J Med. 2025; DOI: 10.1056/NEJMoa2508026 #TACSI #Cardiology #CABG #DAPT #ACS #NEJM #PrecisionMedicine #RCT #BleedingRisk #ClinicalTrials

🧪 NEO-MINDSET Trial 🇧🇷 published in NEJM asks: Can we safely drop aspirin early after PCI in acute coronary syndromes (ACS)? 💊 Monotherapy with ticagrelor/prasugrel reduced bleeding 🩸 but increased early ischemic events 💥 vs dual antiplatelet therapy (DAPT). ❗ Noninferiority for major adverse cardiovascular events was not met. 🔍 DAPT still stands tall in early post-PCI ACS care. Kudos to the Brazilian team for a landmark RCT! 📖 NEJM 2025 | doi: 10.1056/NEJMoa2507980 #NEOMINDSET #PCI #ACS #cardiotwitter #RCT #DAPT #P2Y12 #Bleeding #NEJM #PrecisionMedicine #InterventionalCardiology

🚨 New in NEJM — The ALASCCA Trial 🧬 Low-dose aspirin (160 mg/day) reduced colorectal cancer recurrence in patients with PIK3CA, PIK3R1, or PTEN mutations 🎯 ✅ 3-year recurrence: 7.7% (aspirin) vs 14–17% (placebo) ✅ Group A HR: 0.49 | Group B HR: 0.42 ✅ NNT as low as 6 in stage III rectal cancer 💥 ⚠️ Slight increase in adverse events 🧠 Editorial calls it a new standard of care: 🔬 Genotype early + 💊 Start aspirin early = 📉 Lower recurrence 📖 Read both the trial and editorial in NEJM, Sept 2025 #ColorectalCancer #PrecisionOncology #Aspirin #PIK3CA #NEJM #OncologyTrials #Genomics #AdjuvantTherapy #ALASCCA #ClinicalTrials

💡 TARGET-FIRST trial (NEJM, Aug 2025) shows that in low-risk AMI patients post-PCI with complete revascularization, stopping aspirin after 1 month and continuing P2Y12 monotherapy is noninferior to dual antiplatelet therapy—with 54% fewer bleeding events 🩸🛑💊 ⚖️ A modern, patient-tailored antiplatelet strategy—backed by potent P2Y12 inhibitors and smart selection—might just be the new norm in contemporary cardiology 🫀 📘 New England Journal of Medicine 🔗 https://doi.org/10.1056/NEJMoa2508808 #Cardiology #DAPT #PrecisionMedicine #NEJM #TARGETFIRST

💡 "Cogito, ergo sum" — I think, therefore I am. René Descartes laid the foundation of modern Western philosophy and scientific reasoning, linking algebra to geometry, and mind to body. 🧠📐 His legacy reminds healthcare professionals to unite reason with compassion — science with soul. ❤️⚕️

💊🫀 Aspirin in the Crosshairs? The AQUATIC Trial (NEJM, Aug 2025) raises sharp questions on dual-pathway therapy in chronic coronary syndrome (CCS) patients already on long-term anticoagulation. 📉 Adding aspirin led to: • ↑ Ischemic events (HR 1.53; P=0.02) • ↑ Mortality (HR 1.72; P=0.01) • ↑ Major bleeding (HR 3.35; P) 🧠 Takeaway: More isn't always better. In high-risk CCS, aspirin may harm more than help. 📚 Read: https://www.nejm.org/doi/full/10.1056/NEJMoa2507532 #Cardiology #Antiplatelet #NEJM #PrecisionMedicine #AQUATICTrial

🧠💥 Could lead poisoning have helped shape human evolution? A bold new hypothesis suggests that Homo sapiens may have survived while Neanderthals and Denisovans vanished—thanks to genetic defenses against environmental lead. 🧬 By analyzing fossil teeth 🦷 and testing brain organoids 🧪, researchers found that ancient lead exposure disrupted key language-related genes (like FOXP2)—but not in modern human variants. 👣 Sometimes, evolution turns adversity into advantage. 📖 Published in Science (Oct 2025): "Did lead poisoning help drive human evolution?" 🔗 doi:10.1126/science.aed1022 #Evolution #Neuroscience #Anthropology #Genetics #FOXP2 #NOVA1 #LeadPoisoning #Paleoanthropology #Science 🦴🧬

🚨 New in Nature 🧬: Groundbreaking study reveals how HMGN1, a dosage-sensitive epigenetic regulator on chromosome 21, reprograms atrioventricular cardiomyocytes into a ventricular fate—driving congenital heart defects in Down syndrome 💔🫀. Using hiPSCs, single-cell RNA sequencing, and a CRISPRa CROP-seq screen, researchers pinpoint HMGN1 as a causal gene. Strikingly, reducing its dosage in a trisomy 21 mouse model reversed ventricular septal defects (VSDs) 🔧🐭. This is a model for dissecting aneuploidy-associated disease using human cells + in vivo rescue. Epigenetics meets cardiogenesis in real time. Don't miss this paradigm-shifting work! 📖 DOI: 10.1038/s41586-025-09593-9 #DownSyndrome #Cardiology #Epigenetics #CRISPR #scRNAseq #HMGN1 #CongenitalHeartDefects #StemCells #Nature #GeneDosage #PrecisionMedicine

🚭 Lung Cancer in Nonsmokers – a hidden epidemic affecting up to 20% of global cases 🌍. Unlike tobacco-related disease, this form often strikes younger, female, and Asian populations, with EGFR and ALK mutations driving tumors 🔬. Despite low mutation burden and no smoking history, these patients benefit immensely from targeted therapies like osimertinib and lorlatinib 🎯. Yet, there's no USPSTF recommendation for screening in this group 😔. We must push for awareness, early detection, and precision approaches 🧬. As the review in JAMA (2025) shows, no smoke doesn't mean no risk. 🔗 doi:10.1001/jama.2025.17695 #LungCancer #PrecisionMedicine #Oncology #PublicHealth #JAMA

👟 Just 2 Days Can Make a Difference! 🧓📉 In a large cohort of 13,547 older women (mean age 72), walking ≥4,000 steps/day on even 1–2 days/week was linked to a 26% lower mortality and 27% lower cardiovascular disease risk 💥. Those walking ≥3 days/week had even greater benefits! 📉 Higher step thresholds (up to 7,000/day) showed further mortality reduction—but step volume, not frequency, drove outcomes. 🧠 Message? There's no "perfect pattern"—even weekend walks count. 💡 Time to rethink activity guidelines and empower aging with steps. 📄 Hamaya R et al, Br J Sports Med, 2025. 🔗 https://doi.org/10.1136/bjsports-2025-110311 #Longevity #CardioHealth #WomenInMedicine #PublicHealth #WeekendWarrior #HealthyAging #ExactitudeStudy #StepsToHealth #CVD #ExerciseIsMedicine

🧓 Aging skin, fading flow. This 2025 Nature study uncovers how dermal capillary-associated macrophages (CAMs) decline with age—preceding microvascular dysfunction and impaired blood flow. 🧬 Using intravital imaging and macrophage fate mapping in mice (and validating in humans!), the authors reveal that CAMs are not replenished unless triggered by injury or CSF1. 🛠️ Fascinatingly, local CSF1–Fc therapy restored CAMs and rejuvenated perfusion in aged skin. A compelling case for targeting tissue-resident immunity! 🩸 📖 doi:10.1038/s41586-025-09639-y

🫀📉 Published in The Lancet (Oct 22, 2025): SELECT trial investigators report that semaglutide reduced MACE by 20% in patients with obesity but without diabetes—independent of weight loss. Waist circumference, not weight, tracked with outcomes, yet explained only 33% of the benefit. This landmark analysis redefines GLP-1RAs as disease-modifying agents, not just weight-loss drugs. 👉 Read here: https://doi.org/10.1016/S0140-6736(25)01375-3 #SELECTTrial #Semaglutide #Cardiovascular #Obesity #GLP1RA #TheLancet

Hair Loss in Women" (The New England Journal of Medicine 2025; DOI 10.1056/NEJMcp2412146) 📄, and it's a must‑listen for anyone in clinical practice or research. The piece highlights that female‑pattern hair loss increases with age and is closely tied to hormonal status, and that treatments span from topical 5% minoxidil or low‑dose oral minoxidil to anti‑androgens and adjunctive non‑drug approaches.

🔍 New in The Lancet! A massive network meta-analysis of 94 RCTs (105,435 patients) reveals that antidepressants impact far more than mood 🧠—they alter weight ⚖️, glucose 🩸, BP 💓, lipids 🧬, and liver enzymes 🧪. Agomelatine 🌙 may lower weight, while nortriptyline 📈 raises heart rate. Time to rethink side-effect profiles when prescribing! 📚 Pills, Pressure, and Physiology — catch the full summary & clinical pearls now! #Antidepressants #CardiometabolicHealth #Depression #PrecisionMedicine #Lancet 🧠💊⚖️

🧬 Her Genes, His Risk, Our Mind 💡 New insights from Thomas et al., Nature Communications (2025) — summarized beautifully by Na Cai in Nature News & Views. Women carry a heavier polygenic burden for major depressive disorder (MDD), with ~6,000 female-specific variants and stronger genetic links to metabolic traits like BMI and metabolic syndrome. 🧠 Men show a unique X-chromosome signal (IL1RAPL1), pointing to sex-specific biology in depression. Precision psychiatry must evolve to be sex-aware, data-driven, and equitable. ⚕️ #Genomics #Depression #PrecisionMedicine #SexDifferences #Neurogenetics

🦷🫀 New Findings Linking Oral Health to Heart Attacks! 🧬🧫 Groundbreaking research in JAHA reveals that viridans streptococci, common oral bacteria, form biofilms in atherosclerotic plaques that evade immune detection. These stealthy invaders trigger innate and adaptive immune responses, correlating with plaque rupture, myocardial infarction, and sudden cardiac death. The study combines autopsy data, endarterectomy samples, immunohistochemistry, TLR activation assays, and genome-wide expression to uncover this bacterial-inflammation nexus. 🧠 Could dental hygiene be the next frontier in cardiovascular prevention? 📖 Karhunen et al. JAHA. 2025;14:e041521 🔗 #Cardiology #Immunology #OralHealth #Atherosclerosis #Biofilm #PrecisionMedicine #JAHA #DentalHealth #SuddenCardiacDeath #MultiOmics #CHD #ViridansStreptococci #PlaqueRupture #InnateImmunity #AdaptiveImmunity #TLR2 #NFkB #Streptococcus #MI #Endarterectomy

🧠 Why Does Alzheimer's Affect More Women Than Men? New insights from JAMA Medical News reveal that the answer goes far beyond longevity. 🌸 Biology, hormones, and even social factors intertwine — from estrogen decline and X chromosome genetics to APOE4 risks and underdiagnosis due to stronger verbal memory. Women make up two-thirds of all Alzheimer's cases, yet most clinical trials overlook sex-based analyses. As researchers call for more inclusive designs, one thing is clear — understanding how biology and bias intersect is vital for progress. 💡 🔬 It's time for Alzheimer's research to think beyond averages — and start thinking in X and Y. #AlzheimersDisease #WomensHealth #Neuroscience #PrecisionMedicine #JAMA #SexDifferences #Neurodegeneration

🚨 New Study Alert 🕒 Can when you eat improve how you feel? This open-label pilot study shows that Time-Restricted Eating (TRE) — limiting food intake to an 8–10 hour window — significantly improved: ✅ Quality of Life (↑ SF-36 & ↓ MAPS scores) ✅ Orthostatic Heart Rate (↓ by 11 bpm, p ✅ Mitochondrial ATP production (↑, p TRE may offer a safe, feasible, and non-pharmacological tool for managing Postural Orthostatic Tachycardia Syndrome (POTS) — especially in the Long COVID era. 📄 Dzotsi et al., Scientific Reports, 2025 🔗 https://doi.org/10.1038/s41598-025-16836-2 #TimeRestrictedEating #POTS #LongCOVID #CircadianMedicine #Dysautonomia #LifestyleMedicine #Mitochondria #ClinicalTrials #Cardiology #AutonomicDisorders

🌟 Guru Nanak (1469–1539 CE): The Voice of Oneness & Compassion 🌟 From Ik Onkar (One God) to Seva (selfless service), Guru Nanak's message transcends faith — reminding us that true spirituality lies in equality, honesty, and compassion. 🕊️ His principles — Naam Japo (meditate), Kirat Karo (work honestly), Vand Shhako (share with others) — continue to inspire communities and caregivers alike. 👩‍⚕️👨‍⚕️ 💡 In medicine, his teaching "Serve all, see the divine in all" beautifully aligns with our duty of empathy and ethical care. ❤️ #GuruNanak #Sikhism #Compassion #Oneness #Seva #Healthcare #Ethics #Mindfulness #Inspiration

🚨 New Study Alert 🩺 Think you're low-risk? Think again. This MESA study shows that even "low-risk" individuals may harbor hidden coronary artery calcium (CAC) — and it matters. 📈 Adding CAC scoring significantly improved ASCVD risk prediction, reclassifying up to 18% into statin-eligible groups. 🧠 Implication? Precision prevention may start with a scan. 🔗 Read in American Journal of Preventive Cardiology: https://doi.org/10.1016/j.ajpc.2025.101329 #Cardiology #CAC #RiskStratification #MESA #PreventiveCardiology #PrecisionMedicine #StatinDecisions

🧬 Cellular senescence is more than just a marker of aging — it's a key driver of ❤️ cardiovascular disease. From the p53/p21 and p16/Rb axes to mTOR, SIRT1/6, NF-κB, and ROS/DDR, these molecular pathways halt cell division, fuel inflammation 🔥, and impair cardiac repair. Emerging data spotlight the roles of 💣 SASP, 🧓 senescent MSCs, and 🎯 microRNAs in accelerating vascular aging. Time to rethink how we tackle heart disease — at the cellular level. 🫀 📄 Based on: The role of cellular senescence in cardiovascular disease (doi:10.1038/s41569-023-00899-1) #Cardiology #Senescence #CVD #Inflammaging #PrecisionMedicine #MolecularCardiology #HeartHealth

🚨 Hidden heart risks in plain sight? 🫀🩻 The latest AHA Scientific Statement unveils the power of opportunistic coronary artery calcium (CAC) detection on routine noncardiac chest CTs. With AI-driven automation, we can now detect subclinical atherosclerosis, improve preventive therapy, and bridge disparities—all without additional imaging or cost. 💡 Think Smart. Scan Smarter. Save Lives. 💊🛡️ 📄 Circulation. 2025;152:e•••–e••• 🔗 DOI: 10.1161/CIR.0000000000001382 🧠 #Cardiology #CAC #AIinMedicine #PreventiveCare #Atherosclerosis #HeartHealth #CTScan #Radiology #PrimaryPrevention #HealthcareInnovation

🚨 Pickleball's Popularity Comes at a Price 🎾👁️ As the fastest-growing sport in the U.S. hits 20M players, injuries—especially eye and orthopedic—are rising sharply 📈. New data from JAMA Ophthalmology and JAMA News & Analysis reveal alarming trends: retinal detachments, fractures, falls, and more—mostly in players over 50 👵🧓. Time to talk prevention: 🥽 eye protection, 🦶 proper footwear, 🏋️‍♂️ conditioning, and ✅ awareness. Stay safe on the court—don't let fun turn into a fracture! 🛡️💥 #Pickleball #SportsMedicine #InjuryPrevention #Ophthalmology #PublicHealth

🧬 New insights from Nature Medicine! Researchers reveal that obesity caused by MC4R deficiency — the most common monogenic form — is paradoxically linked to lower LDL-cholesterol, triglycerides, and blood pressure 💡. Despite severe obesity, these individuals show a "metabolically healthier" profile, likely due to altered central melanocortin signaling and reduced sympathetic tone 🧠💓. These findings challenge traditional views on obesity and open doors for MC4R-targeted therapies to reduce cardiometabolic risk 🚀. 📖 Nature Medicine, 2025 — "Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease risk."

🚼 Game-changer in the NICU! Same-day genome sequencing using Sequencing by Expansion (SBX) delivered actionable results in under 7 hours for critically ill infants 🧬⏱️. Two life-altering diagnoses—including KCNQ2-related epilepsy—were identified faster than any existing rapid test. Published in The New England Journal of Medicine 📰. Precision care, now on a NICU clock. 🔗 Read more: https://www.nejm.org/doi/full/10.1056/NEJMc2512825 #Genomics #NICU #PrecisionMedicine #WGS #NEJM #RapidSequencing #Innovation #Pediatrics #DigitalHealth

🩺 Desi Hearts, Hidden Plaques, Bold Truths 💓🫀📊 In the Atherosclerosis journal, Manubolu et al. use AI-powered CCTA to expose an alarming reality: 🧬 Young South Asians have high-risk plaque—even when CAC = 0. 📉 Risk scores fail to capture this. 📸 CCTA sees what traditional tools miss. It's time to personalize prevention for Desi hearts. #CCTA #DesiHeart #PrecisionMedicine #ASCVD #PlaqueParadox #Atherosclerosis #ManuboluStudy #DigitalCardiology

Microplastics — once dismissed as environmental debris — are now being found in the brain, placenta, heart, and bloodstream. 🧠🫀👶 Recent JAMA (2025) and NEJM (2024) studies link them to inflammation, oxidative stress, and higher cardiovascular risk. ⚠️ From beer to baby bottles, no corner of modern life is untouched. 🍺🍼 It's time for urgent global action — from the Basel Convention to the UN Plastics Treaty — to tackle this invisible invasion before it becomes irreversible. 🌊♻️ #Microplastics #EnvironmentalHealth #CardiovascularMedicine #PrecisionHealth #PublicHealth #Sustainability #GlobalHealth #JAMA

🔬 New paradigm for HFpEF! 🧠 The Adipokine Hypothesis reframes preserved EF heart failure as an endocrine disorder driven by dysfunctional visceral fat. 🫀 Adipokines like leptin, aldosterone & neprilysin disrupt volume, inflammation & fibrosis. Target the fat ➡️ fix the heart! 💡 📄 JACC 2025 | Milton Packer MD #HFpEF #Cardiology #Adipokines #VisceralFat #Obesity #HeartFailure

🧠 New study in Nature Medicine links shingles (herpes zoster) to increased dementia risk — but there's hope! 💉 Adults ≥50 who received zoster vaccines (ZVL or RZV) had significantly lower dementia rates 📉. Especially protective in older women 👵. Evidence mounts for VZV reactivation as a modifiable risk factor for neurodegeneration 🧬🛡️. 📚 Read more: https://doi.org/10.1038/s41591-025-03972-5 #Dementia #Neuroinflammation #VZV #Vaccines #PublicHealth #Neurology #Geriatrics #Prevention 🧬💭👩‍⚕️